• 2025 Retina Update, Part 1: Injectables in the Medical Retina Space

  • Jan 23 2025
  • Length: 44 mins
  • Podcast

2025 Retina Update, Part 1: Injectables in the Medical Retina Space

Listen for free

View show details

  • Summary

  • Drs. Ashkan Abbey and Ehsan Rahimy join host Dr. Jay Sridhar to discuss recent developments in the medical retina and injectable space, including faricimab versus high-dose aflibercept, biosimilars for ranibizumab and aflibercept, off-label bevacaziumb shortages, dry age-related macular degeneration (AMD) therapies, private equity acquisitions, and the new drug pipeline.

    For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.
    Show more Show less
Show more Show less

What listeners say about 2025 Retina Update, Part 1: Injectables in the Medical Retina Space

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available